Dexcom at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Dexcom brings 3 presentations to ObesityWeek 2026 in National Harbor, and exhibits at Booth 709. Its program centres on continuous glucose monitoring for adults with type 2 diabetes who do not use insulin, and on how weight relates to outcomes. It covers 18-month weight results from a US primary care registry and the combined effect of real-time monitoring and tirzepatide on HbA1c and BMI.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Dexcom San Diego, CA | |
Maker of continuous glucose monitoring systems that people use to manage diabetes and track their glucose. | Booth Exhibiting at Booth 709 Sat, Nov 147pm–9:30pmSun, Nov 159:30am–4pmMon, Nov 169:30am–4pm Poster Sat Nov 14 7:30pm–8:30pm 18-Month Weight Outcomes with Dexcom G7 CGM in Non-Insulin–Treated T2D: US Primary Care Registry Chronic disease and obesity complicationsObesity pharmacotherapy and drug development Poster Sat Nov 14 7:30pm–8:30pm BMI Differences in Psychosocial and Behavior Outcomes After CGM Use in Adults With Type 2 Diabetes Chronic disease and obesity complicationsMetabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Combined Effect of RT-CGM and Tirzepatide on HbA1c and BMI Change in Type 2 Diabetes not on Insulin Metabolism and integrative physiology |
Find decision makers at Dexcom
Tell us what you sell and we’ll find the people at Dexcom most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction